SCHEMBL5041818

SCHEMBL5041818

CO[C@H](C(=O)NCc1ccc(C#N)cc1)c1ccc(N2CCCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.49
SLC1A2 P43004 2/20 0.48
SLC1A3 P43003 1/20 0.48
PANK3 Q9H999 1/20 0.43
EP300 Q09472 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
HBB P68871 1/20 0.42
KMT2A Q03164 1/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
ENPP2 Q13822 1/20 0.41
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
TSHR P16473 2/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041814 1.00 PKM (0.49) PKMSLC1A2SLC1A3PANK3EP300
SCHEMBL5042653 0.92 PKM (0.47) PKMSLC1A2SLC1A3PANK3EP300
SCHEMBL5042655 0.92 PKM (0.47) PKMSLC1A2SLC1A3PANK3EP300
SCHEMBL5037796 0.83 PKM (0.56) PKMSLC1A2SLC1A3ALDH1A1TSHR
SCHEMBL5037792 0.83 PKM (0.56) PKMSLC1A2SLC1A3ALDH1A1TSHR
SCHEMBL5040508 0.82 PKM (0.72) PKMSLC1A2SLC1A3MEN1ALDH1A1
SCHEMBL5041218 0.82 PKM (0.72) PKMSLC1A2SLC1A3MEN1ALDH1A1
SCHEMBL5040509 0.82 PKM (0.72) PKMSLC1A2SLC1A3MEN1ALDH1A1
Hydrochloric Acid SCHEMBL5047525 0.81 KLKB1 (0.49) PKMHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL5047520 0.81 KLKB1 (0.49) PKMHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885SLC1A2 2127/4885SLC1A3 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.